The previous studies have reported that PAX3 may play an oncogenic function in some cancers such as glioblastomas and melanomas [5, 7], whereas our data suggest that PAX3 acts as an oncosuppressor in thyroid cancer. Here, PAX3 is linked to thyroid cancer.